Director General-Elect Addresses Importance of WIPO Development Agenda

07.07.2008

GENEVA - Francis Gurry, who has been nominated by the Coordination Committee of the World Intellectual Property Organization (WIPO) to become the next Director General of WIPO, emphasized, at the opening of the WIPO Committee on Development and Intellectual Property (CDIP), on July 7, 2008, his commitment to the effective implementation of the WIPO Development Agenda, pledging to personally supervise this important initiative in the future, a press release by WIPO stated.

Stem Cell Therapeutics Announces Issuance of Keystone Prolactin Patents

07.07.2008

CALGARY, ALBERTA - Stem Cell Therapeutics Corp. (SCT) announced in a Monday press release that it has been issued two corresponding patents to strengthen its Intellectual Property (IP) landscape through United States and Australia.

VoiceVerified Wins Patent Approval for Voice Authentication System

06.07.2008

NEW HOPE, PA - VoiceVerified Inc., a software as a service (SaaS) provider of voice biometric technologies, announced the patent approval of its proprietary Point Service Provider (PSP) hosted platform.

Mexico City Selected to Host 34th International Public Meeting

01.07.2008

MARINA DEL REY, CA - The Internet Corporation for Assigned Names and Numbers (ICANN) announced in a Tuesday press release that Mexico City, Mexico will host the Corporation’s 34th International Public Meeting 1-6 March, 2009.

The Artist's Resale Right: The Derogation for Deceased Artists

01.07.2008

LONDON - The UK Intellectual Property Office (UK-IPO) launched on June 30, 2008 a consultation to assess the likely impact of Artist's Resale Right and the derogation for deceased artists on the UK art market, a press release by the Office stated.

TapImmune Issued US Patent Relating to Methods for Enhancing Immune Response

01.07.2008

VANCOUVER - TapImmune Inc. announced in a press release that the US Patent and Trademark Office (USPTO) has issued US patent No. 7,378,087, entitled “Method of Enhancing an Immune Response.” The patent claims relate to methods for enhancing the immune response to tumor cells by introducing the TAP molecule into the infected cells. Patent applications are pending on other aspects of the company’s technology.